Interstitial Lung Disease in Patients With Scleroderma: Treatment With Rituximab

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2010.149013.25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2012English

Emphysematous Change With Scleroderma-Associated Interstitial Lung Disease: The Potential Contribution of Vasculopathy?

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Treated With Rituximab: A Report of 3 Cases in Japan

Internal Medicine
Internal MedicineMedicine
2017English

Effects of Inpatient Pulmonary Rehabilitation in Patients With Interstitial Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Predictors of Progression in Systemic Sclerosis Patients With Interstitial Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2020English

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease

2012English

Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Respiratory Bronchiolitis With Interstitial Lung Disease

2010English

Can Patients With Interstitial Lung Disease Safely Undergo Pulmonary Resection?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy